Tuesday’s Midday Movers: Apache (APA), Rite Aid (RAD), Clovis Oncology (CLVS), Transocean (RIG), TG Therapeutics (TGTX)

So far Tuesday, January 7, NASDAQ is up 0.15% and the S&P is down -0.04%. Here are this morning’s most active stocks: Apache (APAResearch Report), Rite Aid (RADResearch Report), Clovis Oncology (CLVSResearch Report), Transocean (RIGResearch Report) and TG Therapeutics (TGTXResearch Report).

Apache is up 7.2% in midday trading to $32.09. Shares opened today at $29.93. The company has a 52-week low of $18.33 and a 52-week high of $38.12. On the Street’s front, the average 12-month analyst price target for the stock is $24.77, marking a -17.24% potential downside from current levels. In a report released today, Merrill Lynch analyst Chase Mulvehill upgraded APA to Buy, with a price target of $36.00, which implies an upside of 20% from current levels. Separately, on the same day, J.P. Morgan’s Arun Jayaram upgraded the stock to Hold and has a price target of $30.00. In the last 30 days, insiders have sold $1.33M worth of APA shares.

Rite Aid is down -6.71% in midday trading to $12.38. Shares opened today at $13.27. The company has a 52-week low of $5.04 and a 52-week high of $23.88. On the Street’s front, the average 12-month analyst price target for the stock is $12.00, marking a -9.57% potential downside from current levels. In a report issued on December 23, Deutsche Bank analyst George Hill maintained a Sell rating on RAD, with a price target of $12.00, which implies a downside of 10% from current levels. In the last 30 days, insiders have sold $58.13K worth of RAD shares and purchased $499.7K worth of RAD shares.

Clovis Oncology is down -6.25% in midday trading to $8.41. Shares opened today at $8.97. The company has a 52-week low of $2.93 and a 52-week high of $32.05. On the Street’s front, the average 12-month analyst price target for the stock is $12.88, marking a 43.67% potential upside from current levels. In a report issued on November 19, Evercore ISI analyst Joshua Schimmer downgraded CLVS to Hold, with a price target of $8.00, which represents a potential downside of 11% from where the stock is currently trading. Separately, on November 8, H.C. Wainwright’s Edward White reiterated a Buy rating on the stock and has a price target of $36.00. In the last 30 days, insiders purchased $28.92K worth of CLVS shares.

See today’s analyst top recommended stocks >>

Transocean is down -4.83% in midday trading to $6.81. Shares opened today at $7.15. The company has a 52-week low of $3.76 and a 52-week high of $9.79. On the Street’s front, the average 12-month analyst price target for the stock is $7.41, marking a 3.64% potential upside from current levels. In a report released yesterday, Citigroup analyst Scott Gruber maintained a Hold rating on RIG, with a price target of $8.00, which represents a potential upside of 12% from where the stock is currently trading. Separately, on November 19, Deutsche Bank’s Christopher Snyder initiated coverage with a Sell rating on the stock and has a price target of $3.00.

See today’s analyst top recommended stocks >>

TG Therapeutics is up 4.53% in midday trading to $11.54. Shares opened today at $11.04. The company has a 52-week low of $3.87 and a 52-week high of $11.55. On the Street’s front, the average 12-month analyst price target for the stock is $18.50, marking a 67.57% potential upside from current levels. In a report issued on December 10, H.C. Wainwright analyst Edward White reiterated a Buy rating on TGTX, with a price target of $20.00, which implies an upside of 81% from current levels.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.